close

Join our Mailing List

Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.

Tag
Gil Prive
May 01, 2016
OICR invests in early-stage Ontario oncology drug development
OICR invests in early-stage Ontario oncology drug development
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.
Subscribe